Immune Thrombocytopenia
📧 Sign up to get email alerts when something new happens for Immune Thrombocytopenia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-04-30Clinical Trial Update: Real World Evaluation of the Activity and Safety of Fostamatinib in Consecutive Adult Patients With ITP
This real-world study evaluated the activity and safety of fostamatinib in consecutive adults with immune thrombocytopenia, including chroni…
-
CLINICAL_TRIALS trial_result · 2025-04-29Clinical Trial Update: Response Rate and Duration After Discontinuation Thrombopoietin Receptor Agonists Primary Immune Thrombocytopenia
This completed clinical trial update reports on the response rate and duration of response after stopping thrombopoietin receptor agonists i…
-
CLINICAL_TRIALS trial_result · 2025-04-24Clinical Trial Update: A Randomized Trial Comparing Optimized rhTPO Treatment With Eltrombopag Treatment in Pre-treated ITP Pts [Phase 4]
A Phase 4 randomized trial comparing optimized recombinant human thrombopoietin (rhTPO) versus eltrombopag in patients with previously treat…
-
CLINICAL_TRIALS trial_result · 2025-04-23Clinical Trial Update: Study of CM313 (SC) Injection in Subjects With Primary Immune Thrombocytopenia (ITP) [Phase 2]
Phase 2 study of CM313 given as a subcutaneous injection for primary immune thrombocytopenia is currently active but not recruiting. The tri…
-
CLINICAL_TRIALS trial_result · 2025-03-19Clinical Trial Update: Basket Study to Assess Efficacy, Safety and PK of Iptacopan (LNP023) in Autoimmune Benign Hematological Disorders [Phase 2]
A Phase 2 basket study evaluating the efficacy, safety and pharmacokinetics of iptacopan (LNP023) in autoimmune benign hematological disorde…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-03-17Clinical Trial Update: A Study to Assess Efficacy and Safety of Eltrombopag in Combination With a Short Course of Dexamethasone in Patients With Newly Diagnosed ITP [Phase 2]
This update reports results from a Phase 2 study evaluating eltrombopag in combination with a short course of dexamethasone for newly diagno…
-
CLINICAL_TRIALS trial_result · 2025-03-17Clinical Trial Update: Phase III Study on HMPL-523 for Treatment of ITP [Phase 3]
Phase III study of HMPL-523 for Primary Immune Thrombocytopenia is active but not recruiting.
-
CLINICAL_TRIALS trial_result · 2025-03-13Clinical Trial Update: A Study to Assess the Efficacy and Safety of Efgartigimod in Adult Patients With Primary Immune Thrombocytopenia (ITP). [Phase 3]
A Phase 3 trial evaluating efgartigimod in adults with immune thrombocytopenia has completed and posted results.
-
CLINICAL_TRIALS trial_result · 2025-02-24Clinical Trial Update: A Prospective, One-arm and Open Clinical Study of CM313 in the Treatment of Immune Thrombocytopenia [Phase 2]
A Phase 2, prospective, single-arm, open-label study of CM313 in immune thrombocytopenia has completed.
-
CLINICAL_TRIALS trial_result · 2025-02-21Clinical Trial Update: Study of Human Umbilical Cord-derived Mesenchymal Stem Cells for Treatment of Refractory Immune Thrombocytopenia [NA]
The study investigating human umbilical cord-derived mesenchymal stem cells for refractory immune thrombocytopenia has been completed.
-
CLINICAL_TRIALS trial_result · 2025-02-11Clinical Trial Update: Evaluation of Avatrombopag for the Treatment of Thrombocytopenia in Japanese Adults With Chronic ITP [Phase 3]
A Phase 3 trial evaluating avatrombopag for chronic immune thrombocytopenia in Japanese adults has completed and results have been posted.
-
CLINICAL_TRIALS trial_result · 2025-02-11Clinical Trial Update: Evaluation of Avatrombopag for the Treatment of Thrombocytopenia in Japanese Adults With Chronic ITP [Phase 3]
Phase 3 trial evaluating avatrombopag for chronic immune thrombocytopenia in Japanese adults has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2025-01-17Clinical Trial Update: Avatrombopag for the Treatment of Thrombocytopenia in Pediatric Subjects With Immune Thrombocytopenia for ≥6 Months [Phase 3]
Phase 3 trial evaluating avatrombopag for thrombocytopenia in pediatric patients with immune thrombocytopenia for at least 6 months complete…
-
CLINICAL_TRIALS trial_result · 2025-01-17Clinical Trial Update: Avatrombopag for the Treatment of Thrombocytopenia in Pediatric Subjects With Immune Thrombocytopenia for ≥6 Months [Phase 3]
Phase 3 trial evaluating avatrombopag for immune thrombocytopenia in pediatric patients completed with results posted.
-
CLINICAL_TRIALS trial_result · 2025-01-16Clinical Trial Update: Safety and Treatment Satisfaction in Adults With Chronic ITP After Switching to Avatrombopag From Eltrombopag or Romiplostim [Phase 4]
Phase 4 trial updating safety and treatment satisfaction after switching adults with chronic immune thrombocytopenia to avatrombopag from el…
-
CLINICAL_TRIALS trial_result · 2024-12-30Clinical Trial Update: A Randomized, Double-blind, Placebo-controlled, and Multi-center Clinical Study of CM313 in the Treatment of Immune Thrombocytopenia [Phase 2]
Phase 2 randomized, double-blind, placebo-controlled, multi-center trial evaluating CM313 for immune thrombocytopenia; currently ACTIVE_NOT_…
-
CLINICAL_TRIALS trial_result · 2024-11-06Clinical Trial Update: Outcome Study of Conventional Steroids Vs. Steroids Combined with Mycopehnolate in Newly Diagnosed Immune Thrombocytopenia Purpura. [Phase 3]
Phase 3 trial comparing conventional steroids versus steroids combined with mycophenolate mofetil in newly diagnosed immune thrombocytopenia…
-
CLINICAL_TRIALS trial_result · 2024-10-31Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Efgartigimod PH20 Subcutaneous in Adult Patients With Primary Immune Thrombocytopenia [Phase 3]
A Phase 3 trial evaluating the efficacy and safety of subcutaneous efgartigimod PH20 in adults with primary immune thrombocytopenia has comp…
-
CLINICAL_TRIALS trial_result · 2024-10-15Clinical Trial Update: Immunomodulation With Eltrombopag in ITP [Phase 2]
A Phase 2 clinical trial evaluating immunomodulation with eltrombopag in primary immune thrombocytopenia has completed. The study was sponso…
-
CLINICAL_TRIALS trial_result · 2024-09-23Clinical Trial Update: Intravenous Immunoglobulin (IVIG, Bioven) Efficacy and Safety in Chronic Primary Immune Thrombocytopenia (ITP) in Adults [Phase 3]
A Phase 3 clinical trial evaluating intravenous immunoglobulin (Bioven) for efficacy and safety in adults with chronic primary immune thromb…
-
CLINICAL_TRIALS trial_result · 2024-08-12Clinical Trial Update: The Safety and Tolerability of STSA-1301 Subcutaneous Injection in Healthy Subjects [Phase 1]
Phase 1 study assesses the safety and tolerability of a subcutaneous dose of STSA-1301 in healthy subjects; the trial has completed.
-
CLINICAL_TRIALS trial_result · 2024-08-07Clinical Trial Update: Study to Evaluate the Efficacy and Safety of PANZYGA in Pediatric Patients With Chronic Immune Thrombocytopenia (ITP) [Phase 4]
Phase 4 trial evaluating PANZYGA in pediatric Chronic Immune Thrombocytopenia has been terminated; results were posted in 2024.
-
CLINICAL_TRIALS trial_result · 2024-07-30Clinical Trial Update: TPO-RAs Combining Anti-CD 20 Monoclonal Antibody Versus TPO-RAs in the Management of Pediatric Primary Immune Thrombocytopenia (ITP) [Phase 4]
Phase 4 trial evaluating adding an anti-CD20 monoclonal antibody to thrombopoietin receptor agonists for pediatric immune thrombocytopenia, …
-
CLINICAL_TRIALS trial_result · 2024-07-16Clinical Trial Update: The Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of HMPL-523 in Immune Thrombocytopenia Patients [Phase 1]
This Phase 1 study reports safety, tolerability, pharmacokinetics and preliminary efficacy of HMPL-523 in patients with immune thrombocytope…
-
CLINICAL_TRIALS trial_result · 2024-07-16Clinical Trial Update: Human Mass Balance of [14C]HMPL-523 in Healthy Adult Male Chinese Subjects [Phase 1]
Phase 1 mass-balance pharmacokinetics study of [14C]HMPL-523 in healthy adult male Chinese subjects completed, sponsored by Hutchmed.